Purchase of a confocal microscope for Plymouth Light Microscopy Services (PLiMS) at Peninsula Medical School

点击翻译按钮获取中文摘要

We apply for the purchase of a specialised microscope for the light microscopy core facility at the Derriford Research Facility (DRF), Faculty of Health, University of Plymouth.In 2017 the University of Plymouth opened the DRF next to the University Hospitals Plymouth NHS Trust. This major investment by the University strengthened and facilitated its medical research by locating medical and biomedical teams into the same building. The location next to the hospital was chosen to underpin the translational character of the investigations from basic molecular discoveries to clinical trials to find and establish new treatments. Our teams' research falls into the remit of the MRC, focusing on infection and immunity, molecular and cellular medicine, neurosciences and mental health, antimicrobial resistance, obesity research and regenerative medicine and stem cells.Due to our national and international success the DRF grew significantly since its opening. The research accomplishments of our scientists depend on the use of highly specialised microscopes, confocal microscopes. These machines yield precise images of molecules in biopsies and other samples which are necessary not only for the diagnosis and study of diseases but also to follow efficacy of treatments. Currently, we have two confocal microscopes serving 44 researchers, of which one is already 10 years old and the other is a 5-year old basic model. Both are heavily used, with a waiting time of 14 days for either. This severely hampers progress of our research and discovery of new treatments. A third confocal microscope will shorten our waiting times to 2 to 3 days. Critically, we not only need a new machine to strengthen existing research but we want to look into the future and enter new research avenues to stay competitive and productive. The proposed microscope is equipped with a new state-of-the-art laser, novel high-sensitive detectors and a novel laser application allowing to gain insight into deep tissues. These are the features we identified as required to be at the forefront of discovery in future biomedical research. Our internationally recognised research excellence is well illustrated by work on the discovery of brain tumour therapies and on novel antibiotics. Brain tumours are the most common and lethal of cancers in young adults and children, making treatment discovery extremely urgent. Treatment development in our Brain Tumour Centre of Excellence requires multiplexed imaging, recording up to 12 different molecules simultaneously in one tumour sample. Our microscopes only allow us to detect 5 molecules. Speed and capacity to determine tumour composition with multiplexing is key for identification and probing the efficacy of treatment options. The growing resistance against available antibiotics threatens to leave us defenceless against infections, which would make even minor skin cuts potentially lethal. It is therefore pivotal to discover new antibiotics. The microscopes at our facility are not able to detect bacteria. The proposed microscope would allow us to detect up to 12 different bacteria in one sample per day and quickly test the efficacy of new antibiotics, which we are successfully isolating from deep sea sponges among other sources. Finally, the requested confocal microscope will be part of a well-established, supervised and core funded imaging facility, which runs smoothly. All users will be trained and benefit from on-site, on-demand assistance. Together with the planned and paid regular servicing, the machine will be well-cared for and used for decades.In summary, the pressing need for a new confocal microscope due to capacity and capability limitations of our extant microscopes will guarantee an efficient use of the new machine. The proposed microscope's novel tools and its modular versatile base will enable our research excellence to grow and generate outstanding results.